The legacy of Viagra, and its developer copyright, presents a complex case study for investors. At first a blockbuster drug, yielding billions in income, its intellectual property lapse created a flood of knock-off medications, significantly impacting its market share . While certain businesses may attempt to capitalize on related treatments , the